top of page
THE PACE
New therapies / indications available since the last 12 months
XACDURO®
BY:
Dr. Feng Xue
Apr 28, 2026
XACDURO®
(durlobactam, as sodium; sulbactam, as sodium) ZAI LAB HK Reg. No. HK-68971 (29 Jan, 2026)
Composition3:XACDUROA® is a co-packaged kit containing the following two components as sterile powders for reconstitution:
• 1 clear single-dose vial of sulbactam for injection 1 g and
• 2 amber single-dose vials of durlobactam for injection 0.5 g
Indication3:XACDURO® is indicated in patients 18 years of age and older for the treatment of hospital acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex
References
3. FDA. Highlights of Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216974s000lbl.pdf. [Accessed 12 March 2026].
POPULAR STORY
bottom of page
.png)





